Prediction of In-vivo efficacy by In-vitro early bactericidal activity with oral β-lactams, in a dose-ranging immunocompetent mouse sepsis model, using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin

1. Pérez-Trallero, E.
2. Alkorta, M.
3. Giménez, M.J.
4. Vicente, D.
5. Aguilar, L.